Skip to main content
. 2022 Jul 5;10(7):1599. doi: 10.3390/biomedicines10071599

Table 2.

Demographic and clinical data of the study participants.

Parameter Total Sample NCP (NPS Score < 4) CP (NPS Score ≥ 4) p-Value (NCP Compared to CP)
N 147 97 50 (34%)
Mean Age (SD, range) 42.5 (16.4, 18–89) 42.2 (17.5, 18–89) 42.9 (14.0, 20–74) p > 0.1
Sex p > 0.1
Female (percent) 45 (30.6) 28 (28.9) 17 (34.0)
Male (percent) 102 (69.4) 69 (71.1) 33 (66.0)
Race/Ethnicity 0.09
Non-Hispanic White 68 (46.3) 52 (53.6) 16 (32.0)
Black or African American 66 (44.9) 37 (38.1) 29 (58.0)
Hispanic or Latino 11 (7.5) 7 (7.2) 4 (8.0)
Native American/Alaskan Native 2 (1.4) 1 (1) 1 (2)
Highest Educational Level Completed 0.09
Advanced degree (master’s or higher) 10 (6.8) 10 (10.3) 0 (0.0)
College graduate 24 (16.3) 15 (15.5) 9 (18.0)
Graduated high school, some college 52 (35.4) 37 (38.1) 15 (30.0)
High school graduate, no college 36 (24.4) 20 (20.6) 16 (32.0)
Less than high school 25 (17.0) 15 (15.5) 10 (20.0)
In a committed relationship 0.056
No 57 (39.3) 32 (33.7) 25 (50.0)
Yes 88 (60.7) 63 (66.3) 25 (50.0)
Time between injury and follow-up assessment for chronic pain and blood draw (SD, range) 192 days (22, 156–286) 191 (19, 156–240) 194 (26, 160–286) p > 0.1
Injury severity score (ISS; SD, range) 10.1 (5.9, 0–29) 9.1 (5.2, 0–24) 12.2 (6.6, 0–29) 0.002
Numerical pain score at hospitalization (SD, range) 5.8 (2.4, 0–10) 5.2 (2.3, 0–10) 6.9 (2.3, 1–10) <0.001

NCP: no chronic pain and CP: chronic pain subgroups determined at follow-up. Age, time between injury and follow-up, severity scores (ISS), and acute pain scores were compared between the NCP and CP groups using Mann–Whitney non-parametric t-tests; other comparisons were made using the Chi-squared test.